These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1995529)
1. Definitive radiation therapy for localized prostatic adenocarcinoma. Arcangeli G; Micheli A; Arcangeli G; Pansadoro V; De Paula F; Giannarelli D; Benassi M Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):439-46. PubMed ID: 1995529 [TBL] [Abstract][Full Text] [Related]
2. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Kupelian PA; Buchsbaum JC; Patel C; Elshaikh M; Reddy CA; Zippe C; Klein EA Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):704-11. PubMed ID: 11849793 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371 [TBL] [Abstract][Full Text] [Related]
4. Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint. Perez CA; Michalski JM; Lockett MA Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1287-96. PubMed ID: 11286836 [TBL] [Abstract][Full Text] [Related]
5. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. Perez CA; Hanks GE; Leibel SA; Zietman AL; Fuks Z; Lee WR Cancer; 1993 Dec; 72(11):3156-73. PubMed ID: 7694785 [TBL] [Abstract][Full Text] [Related]
6. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Zagars GK; von Eschenbach AC; Johnson DE; Oswald MJ Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):701-9. PubMed ID: 3350725 [TBL] [Abstract][Full Text] [Related]
7. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate. Perez CA; Michalski J; Brown KC; Lockett MA Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341 [TBL] [Abstract][Full Text] [Related]
8. High-dose radiotherapy for localized prostatic cancer. An analysis of treatment results and early complications. Kearsley JH Med J Aust; 1986 Jun; 144(12):624-8. PubMed ID: 3086680 [TBL] [Abstract][Full Text] [Related]
9. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625 [TBL] [Abstract][Full Text] [Related]
11. Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Kupelian PA; Mohan DS; Lyons J; Klein EA; Reddy CA Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):567-74. PubMed ID: 10701735 [TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months. Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T; Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908 [TBL] [Abstract][Full Text] [Related]
13. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. Perez CA; Pilepich MV; Garcia D; Simpson JR; Zivnuska F; Hederman MA NCI Monogr; 1988; (7):85-94. PubMed ID: 3173506 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987. Hahn P; Baral E; Cheang M; Math MC; Kostyra J; Roelss R Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):41-7. PubMed ID: 12118564 [TBL] [Abstract][Full Text] [Related]
15. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. Kupelian PA; Buchsbaum JC; Elshaikh MA; Reddy CA; Klein EA Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):629-34. PubMed ID: 14529766 [TBL] [Abstract][Full Text] [Related]
16. Improvement in prostate cancer survival over time: a 20-year analysis. Kim MM; Hoffman KE; Levy LB; Frank SJ; Pugh TJ; Choi S; Nguyen QN; McGuire SE; Lee AK; Kuban DA Cancer J; 2012; 18(1):1-8. PubMed ID: 22290249 [TBL] [Abstract][Full Text] [Related]
17. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636 [TBL] [Abstract][Full Text] [Related]
19. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. Rosser CJ; Levy LB; Kuban DA; Chichakli R; Pollack A; Lee A; Pisters LL J Urol; 2003 Jun; 169(6):2160-5. PubMed ID: 12771739 [TBL] [Abstract][Full Text] [Related]
20. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]